| # | Drug | Count |
|---|---|---|
| 0 | AZATHIOPRINE | 2 |
| 1 | INFLIXIMAB | 2 |
| 2 | CYTARABINE | 1 |
| 3 | DOXORUBICIN | 1 |
| 4 | ETOPOSIDE | 1 |
| 5 | NELARABINE | 1 |
| 6 | VENETOCLAX | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELARABINE | 1 | 0.0010 |
| 1 | AZATHIOPRINE | 2 | 0.0000 |
| 2 | CYTARABINE | 1 | 0.0000 |
| 3 | VENETOCLAX | 1 | 0.0000 |
| 4 | ETOPOSIDE | 1 | 0.0000 |
| 5 | DOXORUBICIN | 1 | 0.0000 |
| 6 | INFLIXIMAB | 2 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 2 |
| 1 | Purine Antimetabolite [EPC] | 2 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 2 |
| 3 | BCL-2 Inhibitor [EPC] | 1 |
| 4 | Topoisomerase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 1 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 2 | 0.0000 |